Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Weis Bjerrum

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Drug Discovery Today|May 21, 2022
Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemiaBenjamin Micallef, Robert Nistico, Ole Weis Bjerrum, et al.
Ugeskrift for Laeger|January 12, 2016
[Positive results with haematology webcasting for junior doctors]Klas Raaschou-Jensen, Rasmus Heje Thomsen, Anne Ortved Gang, et al.
Histopathology|January 19, 2012
A novel immunohistochemical sequential multi-labelling and erasing technique enables epitope characterization of bone marrow pericytes in primary myelofibrosisAnn Madelung, Michael Bzorek, Henrik Bondo, et al.
Leukemia & Lymphoma|May 10, 2015
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia veraCecilie Utke Rank, Ole Weis Bjerrum, Thomas Stauffer Larsen, et al.
Ugeskrift for Laeger|November 6, 2009
[Eosinophilia--pathogenesis, classification and therapy]Christen Lykkegaard Andersen, Hanne Vestergaard, Peter Nørgaard, et al.
Clinical Epidemiology|June 27, 2014
The Copenhagen Primary Care Differential Count (CopDiff) databaseChristen Lykkegaard Andersen, Volkert Dirk Siersma, Willy Karlslund, et al.
Blood|June 29, 2011
Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-αCaroline Hasselbalch Riley, Morten Krogh Jensen, Marie Klinge Brimnes, et al.
Leukemia & Lymphoma|December 3, 2016
The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasmsVibe Skov, Caroline Hasselbalch Riley, Mads Thomassen, et al.
Leukemia Research|April 8, 2011
High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosisHans Carl Hasselbalch, Vibe Skov, Thomas Stauffer Larsen, et al.
Acta Haematologica|May 3, 2018
Myeloproliferative Neoplasms in Danish TwinsMichael Asger Andersen, Ole Weis Bjerrum, Ajenthen Ranjan, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Drug Discovery Today|May 21, 2022
Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemiaBenjamin Micallef, Robert Nistico, Ole Weis Bjerrum, et al.
Ugeskrift for Laeger|January 12, 2016
[Positive results with haematology webcasting for junior doctors]Klas Raaschou-Jensen, Rasmus Heje Thomsen, Anne Ortved Gang, et al.
Histopathology|January 19, 2012
A novel immunohistochemical sequential multi-labelling and erasing technique enables epitope characterization of bone marrow pericytes in primary myelofibrosisAnn Madelung, Michael Bzorek, Henrik Bondo, et al.
Leukemia & Lymphoma|May 10, 2015
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia veraCecilie Utke Rank, Ole Weis Bjerrum, Thomas Stauffer Larsen, et al.
Ugeskrift for Laeger|November 6, 2009
[Eosinophilia--pathogenesis, classification and therapy]Christen Lykkegaard Andersen, Hanne Vestergaard, Peter Nørgaard, et al.
Clinical Epidemiology|June 27, 2014
The Copenhagen Primary Care Differential Count (CopDiff) databaseChristen Lykkegaard Andersen, Volkert Dirk Siersma, Willy Karlslund, et al.
Blood|June 29, 2011
Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-αCaroline Hasselbalch Riley, Morten Krogh Jensen, Marie Klinge Brimnes, et al.
Leukemia & Lymphoma|December 3, 2016
The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasmsVibe Skov, Caroline Hasselbalch Riley, Mads Thomassen, et al.
Leukemia Research|April 8, 2011
High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosisHans Carl Hasselbalch, Vibe Skov, Thomas Stauffer Larsen, et al.
Acta Haematologica|May 3, 2018
Myeloproliferative Neoplasms in Danish TwinsMichael Asger Andersen, Ole Weis Bjerrum, Ajenthen Ranjan, et al.
Pageof 7